Aequus Pharmaceuticals (TSXV:AQS) Accounts Payable : C$0.45 Mil (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Aequus Pharmaceuticals Accounts Payable?

Aequus Pharmaceuticals's Accounts Payable for the quarter that ended in Sep. 2024 was C$0.45 Mil.

Aequus Pharmaceuticals's quarterly Accounts Payable increased from Mar. 2024 (C$0.34 Mil) to Jun. 2024 (C$0.35 Mil) and increased from Jun. 2024 (C$0.35 Mil) to Sep. 2024 (C$0.45 Mil).

Aequus Pharmaceuticals's annual Accounts Payable declined from Dec. 2021 (C$0.16 Mil) to Dec. 2022 (C$0.09 Mil) but then increased from Dec. 2022 (C$0.09 Mil) to Dec. 2023 (C$0.27 Mil).

Aequus Pharmaceuticals Accounts Payable Historical Data

The historical data trend for Aequus Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aequus Pharmaceuticals Accounts Payable Chart

Aequus Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

0.25

0.16

0.09

0.27

Aequus Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable	Get a 7-Day Free Trial															0.50	0.27	0.34	0.35	0.45

Aequus Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Aequus Pharmaceuticals Accounts Payable Related Terms

Thank you for viewing the detailed overview of Aequus Pharmaceuticals's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Aequus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aequus Pharmaceuticals Inc (TSXV:AQS) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

AQSZF:USA AEQ:Germany

Address

200 Granville Street, Suite 2820, Vancouver, BC, CAN, V6C 1S4

Website

https://www.aequuspharma.ca

Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.

Executives

Doug Janzen

Director, Senior Officer

Aequus Pharmaceuticals Headlines

No Headlines